Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
New inhibitors of β-1,4-galactosyltransferase I discovered by virtual screening
ID
Kranjc, Jaka
(
Author
),
ID
Tomašič, Tihomir
(
Author
),
ID
Pajk, Stane
(
Author
),
ID
Brinc, Matjaž
(
Author
),
ID
Pišlar, Anja
(
Author
),
ID
Anderluh, Marko
(
Author
)
PDF - Presentation file,
Download
(1,11 MB)
MD5: 0696283F1B4299FB4E8114BFF001F422
URL - Source URL, Visit
https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202400896
Image galllery
Abstract
Seven different enzymes comprise the galactosyltransferases family, of which β-1,4-galactosyltransferase I (β-1,4-GALT1) is the major contributor to galactosylation activity in cells. Since abnormalities in galactosylation are associated with many pathophysiological conditions, β-1,4-GALT1 is an interesting new target for drug discovery and molecular probe design. There are several known β-1,4-GALT1 inhibitors, but most of them suffer from low cell permeability and thus low in vivo activity. In the present work, we describe an in silico screening performed using commercially available virtual compound libraries that led us to the discovery of novel β-1,4-GALT1 inhibitors. A virtual screening campaign was performed by docking compound libraries to the binding site of β-1,4-GALT1, followed by biological evaluation of selected hits for their β-1,4-GALT1 inhibitory activity. The IC$_{50}$ values were determined for the best performing inhibitors to obtain new chemotypes of β-1,4-GALT1 inhibitors.
Language:
English
Keywords:
β-1
,
4-GALT1 inhibitors
,
galactosylation
,
β-1
,
4-galactosyltransferase I
,
enzyme inhibitor
,
galactosyltransferase
,
UDP-Glo assay
,
virtual screening
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
6 str.
Numbering:
Vol. 20, iss. 7, art. e202400896
PID:
20.500.12556/RUL-168197
UDC:
615.4:54
ISSN on article:
1860-7187
DOI:
10.1002/cmdc.202400896
COBISS.SI-ID:
223097859
Publication date in RUL:
02.04.2025
Views:
409
Downloads:
109
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ChemMedChem
Shortened title:
ChemMedChem
Publisher:
Wiley, Chemistry Europe
ISSN:
1860-7187
COBISS.SI-ID:
519053337
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Secondary language
Language:
Slovenian
Keywords:
galaktoziltransferaza
,
galaktozilacija
,
zaviralci β-1
,
4-GALT1
,
farmacevtska kemija
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Project number:
P4-0127
Name:
Farmacevtska biotehnologija: znanost za zdravje
Funder:
Novartis Pharmaceutical Manufacturing LLC
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back